Dr. Shady Abdelbaki, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 501 W 14th St, Wilmington, DE 19801 Phone: 302-320-2490 Fax: 302-623-4395 |
Dr. Philip Schwartz, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1902 N Scott St, Rheumatology Consultants, Wilmington, DE 19806 Phone: 302-655-0121 Fax: 302-655-4993 |
James Newman, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 501 W 14th St, Rm5225, Wilmington, DE 19801 Phone: 302-428-2904 |
Shakaib S Qureshi, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3301 Lancaster Pike, Suite 9, Wilmington, DE 19805 Phone: 302-830-5297 Fax: 302-656-5270 |
Dr. Madhavi Valiveti, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1601 Kirkwood Hwy, Wilmington, DE 19805 Phone: 302-633-5302 Fax: 302-633-5582 |
Dr. Nancy G Murphy, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2500 Grubb Rd, Suite 114, Wilmington, DE 19810 Phone: 302-529-9303 Fax: 302-529-9410 |
News Archive
Like a skittish driver slamming the brakes, a special class of T cells may be limiting the effectiveness of therapeutic vaccines for HIV by slowing the immune system response too soon, report University of Pittsburgh health science researchers in the current issue of PLoS ONE. Their study, the first to look at the role of regulatory T cells in therapeutic HIV vaccines, may help researchers improve the efficacy of such vaccines by devising methods to circumvent the braking mechanism of these cells.
A survey of GPs (general practitioners) in the UK and Sweden revealed that some hold the view that one of the greatest health risks from smoking is nicotine. This belief likely influences health advice to smokers when considering whether to recommend the use of alternative nicotine products.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
A medical device trade group and former lawmaker separately called on the White House to do more to promote life-saving medical innovation this week. "In separate events Wednesday and Thursday, former House Majority Leader Dick Gephardt (D-Mo.) and Stephen Ubl, the head of the medical device trade group AdvaMed, called on the Obama administration to task a federal office with promoting U.S. innovation."
› Verified 6 days ago